Premature Ventricular Complexes
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
ZywieExtended nocturnal use of auricular vagus nerve stimulator device
AbbottPacing interventions
Clinical Trials (2)
Total enrollment: 19 patients across 2 trials
Sustained Auricular Nerve Stimulation for PVC Suppression
Start: Jul 2025Est. completion: May 202616 patients
N/AEnrolling By Invitation
Optimal EGM Configuration for Morphology Discrimination
Start: Apr 2009Est. completion: May 20103 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.